CN101703428B - 一种具有防再狭窄涂层的血管支架及其制备方法 - Google Patents
一种具有防再狭窄涂层的血管支架及其制备方法 Download PDFInfo
- Publication number
- CN101703428B CN101703428B CN2009102160080A CN200910216008A CN101703428B CN 101703428 B CN101703428 B CN 101703428B CN 2009102160080 A CN2009102160080 A CN 2009102160080A CN 200910216008 A CN200910216008 A CN 200910216008A CN 101703428 B CN101703428 B CN 101703428B
- Authority
- CN
- China
- Prior art keywords
- coating layer
- intravascular stent
- restenosis
- metal rack
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000037803 restenosis Diseases 0.000 title claims abstract description 56
- 239000011247 coating layer Substances 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title description 24
- 238000005507 spraying Methods 0.000 claims abstract description 53
- 230000001028 anti-proliverative effect Effects 0.000 claims abstract description 48
- 229920000642 polymer Polymers 0.000 claims abstract description 42
- 230000003628 erosive effect Effects 0.000 claims abstract description 34
- 239000003814 drug Substances 0.000 claims abstract description 30
- 239000011248 coating agent Substances 0.000 claims description 53
- 238000000576 coating method Methods 0.000 claims description 53
- 239000002184 metal Substances 0.000 claims description 53
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 46
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- 238000001035 drying Methods 0.000 claims description 34
- 230000010355 oscillation Effects 0.000 claims description 34
- 238000001291 vacuum drying Methods 0.000 claims description 34
- 239000004380 Cholic acid Substances 0.000 claims description 27
- 229960002471 cholic acid Drugs 0.000 claims description 27
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 26
- 239000004626 polylactic acid Substances 0.000 claims description 26
- 238000007151 ring opening polymerisation reaction Methods 0.000 claims description 26
- 150000008064 anhydrides Chemical class 0.000 claims description 25
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 24
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 claims description 23
- 235000019416 cholic acid Nutrition 0.000 claims description 23
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 claims description 23
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical group C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 18
- 238000004140 cleaning Methods 0.000 claims description 17
- 229950009819 zotarolimus Drugs 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 229960001592 paclitaxel Drugs 0.000 claims description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 10
- 229960002930 sirolimus Drugs 0.000 claims description 10
- 229960001967 tacrolimus Drugs 0.000 claims description 9
- 229960005309 estradiol Drugs 0.000 claims description 8
- 229960005167 everolimus Drugs 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 229960005330 pimecrolimus Drugs 0.000 claims description 8
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 7
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 7
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 5
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 claims description 5
- 229930012538 Paclitaxel Natural products 0.000 claims description 5
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims description 5
- 229930182833 estradiol Natural products 0.000 claims description 5
- KASDHRXLYQOAKZ-ZPSXYTITSA-N pimecrolimus Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](Cl)[C@H](OC)C1 KASDHRXLYQOAKZ-ZPSXYTITSA-N 0.000 claims description 5
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 claims description 5
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 2
- YYSFXUWWPNHNAZ-PKJQJFMNSA-N umirolimus Chemical compound C1[C@@H](OC)[C@H](OCCOCC)CC[C@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 YYSFXUWWPNHNAZ-PKJQJFMNSA-N 0.000 claims description 2
- CGTADGCBEXYWNE-JUKNQOCSSA-N zotarolimus Chemical compound N1([C@H]2CC[C@@H](C[C@@H](C)[C@H]3OC(=O)[C@@H]4CCCCN4C(=O)C(=O)[C@@]4(O)[C@H](C)CC[C@H](O4)C[C@@H](/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C3)OC)C[C@H]2OC)C=NN=N1 CGTADGCBEXYWNE-JUKNQOCSSA-N 0.000 claims description 2
- 238000006731 degradation reaction Methods 0.000 abstract description 10
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 230000000593 degrading effect Effects 0.000 abstract description 2
- 238000000889 atomisation Methods 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 description 6
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 206010020880 Hypertrophy Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 125000003716 cholic acid group Chemical group 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102160080A CN101703428B (zh) | 2009-10-28 | 2009-10-28 | 一种具有防再狭窄涂层的血管支架及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102160080A CN101703428B (zh) | 2009-10-28 | 2009-10-28 | 一种具有防再狭窄涂层的血管支架及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101703428A CN101703428A (zh) | 2010-05-12 |
CN101703428B true CN101703428B (zh) | 2012-05-09 |
Family
ID=42373728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102160080A Active CN101703428B (zh) | 2009-10-28 | 2009-10-28 | 一种具有防再狭窄涂层的血管支架及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101703428B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327862B (zh) * | 2011-07-12 | 2014-03-12 | 成都西南交大科技园管理有限责任公司 | 一种可降低镁基材料及其器件腐蚀速率的聚合物复合涂层技术 |
CN102727944A (zh) * | 2011-11-14 | 2012-10-17 | 上海市第一人民医院 | 抗胆管良、恶性狭窄的药物涂层支架及制备方法 |
CN103566418B (zh) * | 2013-08-13 | 2016-01-20 | 重庆大学 | 一种多层涂层药物洗脱血管支架的制备方法 |
CN104971387B (zh) * | 2015-07-17 | 2017-10-17 | 中科益安医疗科技(北京)股份有限公司 | 一种超声雾化喷涂方式制备药物涂层心血管支架的方法 |
CN105833360B (zh) * | 2016-03-25 | 2019-04-16 | 西南交通大学 | 一种抗血管钙化可降解载药涂层支架的制备方法 |
CN113018518B (zh) * | 2021-03-05 | 2022-06-03 | 上海交通大学医学院附属新华医院 | 一种用于婴幼儿狭窄血管可吸收血管支架涂层的制备方法 |
-
2009
- 2009-10-28 CN CN2009102160080A patent/CN101703428B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101703428A (zh) | 2010-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101703428B (zh) | 一种具有防再狭窄涂层的血管支架及其制备方法 | |
CN101185779B (zh) | 一种药物缓释支架的制备方法 | |
Ma et al. | Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies | |
JP4493655B2 (ja) | 薬物ポリマコーティングをステントに施す方法 | |
KR100679990B1 (ko) | 재협착증의 방지를 위한 스텐트의 코팅 | |
EP2046410B1 (de) | Herstellung, verfahren und verwendung von wirkstofffreisetzenden medizinprodukten zur permanenten offenhaltung von blutgefässen | |
US20050043788A1 (en) | Drug-eluting stent | |
CN1725988A (zh) | 具有多孔层的医用装置及其制造方法 | |
CN103566414B (zh) | 一种核壳结构纳微粒涂层血管支架及其制备方法 | |
KR20090122202A (ko) | 생분해성 혈관 지지체 | |
CN103566418A (zh) | 一种多层涂层药物洗脱血管支架的制备方法 | |
CN107496996A (zh) | 一种负载药物的血管支架及其制备方法 | |
Kim et al. | A method for coating fucoidan onto bare metal stent and in vivo evaluation | |
CN103566415A (zh) | 一种双面涂层的人体血管植入物及其制作方法 | |
CN100577221C (zh) | 血管支架的表面改性涂层及其制备方法 | |
CN101195048A (zh) | 一种复合药物洗脱支架及其制备方法 | |
CN101081316A (zh) | 一种新型药物洗脱支架 | |
CN104587535A (zh) | 一种生物可降解聚合物涂层载药镁合金洗脱支架 | |
CN100346850C (zh) | 一种药物涂层支架 | |
CN101007187B (zh) | 一种复合药物洗脱支架及其药物涂层的制备方法 | |
CN101711710A (zh) | 药物洗脱支架及其制备方法 | |
CN107496998B (zh) | 外周药物洗脱支架及其制备和应用 | |
CN101584888A (zh) | 一种药物释放血管支架及其制备方法 | |
CN113476669A (zh) | 一种药物涂层组合物及其涂覆工艺 | |
CN104491935A (zh) | 一种生物可降解聚合物涂层载药镁合金洗脱支架 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHENGDU NORTHWEST JIAO TONG UNIVERSITY SCIENGCE AN Free format text: FORMER OWNER: SOUTHWEST JIAOTONG UNIVERSITY Effective date: 20120801 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120801 Address after: 610031 Sichuan City, Chengdu Province, No. two North Ring Road, No. 111 Patentee after: Chengdu Southwest Jiaotong University Tech Park Management Co., Ltd. Address before: 610031 Sichuan City, Chengdu Province, No. two North Ring Road, No. 111 Patentee before: Southwest Jiaotong University |
|
ASS | Succession or assignment of patent right |
Owner name: CHENGDU JIAODA MAIDIKE TECHNOLOGY CO., LTD. Effective date: 20130407 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130407 Address after: 610031 Sichuan City, Chengdu Province, No. two North Ring Road, No. 111 Patentee after: Chengdu Southwest Jiaotong University Tech Park Management Co., Ltd. Patentee after: Chengdu Jiaoda Maidike Technology Co., Ltd. Address before: 610031 Sichuan City, Chengdu Province, No. two North Ring Road, No. 111 Patentee before: Chengdu Southwest Jiaotong University Tech Park Management Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: CHENGDU SOUTHWEST JIAOTONG UNIVERSITY RESEARCH INS Free format text: FORMER OWNER: CHENGDU SOUTHWEST JIAOTONG UNIVERSITY TECH PARK MANAGEMENT CO., LTD. Effective date: 20141226 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 610031 CHENGDU, SICHUAN PROVINCE TO: 610225 CHENGDU, SICHUAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141226 Address after: 610225 Research Institute of Southwest Jiao Tong University, Shuangliu County Southwest Economic Zone, Chengdu, Sichuan Patentee after: CHENGDU SOUTHWEST JIAOTONG UNIVERSITY RESEARCH INSTITUTE CO., LTD. Patentee after: Chengdu Jiaoda Maidike Technology Co., Ltd. Address before: 610031 Sichuan City, Chengdu Province, No. two North Ring Road, No. 111 Patentee before: Chengdu Southwest Jiaotong University Tech Park Management Co., Ltd. Patentee before: Chengdu Jiaoda Maidike Technology Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 610225 Research Institute of Southwest Jiaotong University, Southwest Airport Economic Development Zone, Shuangliu County, Chengdu City, Sichuan Province Co-patentee after: Chengdu Dingfeng Forward-looking Technology Co., Ltd. Patentee after: CHENGDU SOUTHWEST JIAOTONG UNIVERSITY RESEARCH INSTITUTE CO., LTD. Address before: 610225 Research Institute of Southwest Jiaotong University, Southwest Airport Economic Development Zone, Shuangliu County, Chengdu City, Sichuan Province Co-patentee before: Chengdu Jiaoda Maidike Technology Co., Ltd. Patentee before: CHENGDU SOUTHWEST JIAOTONG UNIVERSITY RESEARCH INSTITUTE CO., LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190517 Address after: 610000 Office Building 308, Modern Industrial Center, Southwest Jiaotong University, 111 North Section of Second Ring Road, Jinniu District, Chengdu City, Sichuan Province Co-patentee after: Beijing Natong Technology Group Co., Ltd. Patentee after: Chengdu Dingfeng Forward-looking Technology Co., Ltd. Address before: 610225 Research Institute of Southwest Jiaotong University, Southwest Airport Economic Development Zone, Shuangliu County, Chengdu City, Sichuan Province Co-patentee before: Chengdu Dingfeng Forward-looking Technology Co., Ltd. Patentee before: CHENGDU SOUTHWEST JIAOTONG UNIVERSITY RESEARCH INSTITUTE CO., LTD. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20191012 Address after: Room 306, building B, Beidou Industrial Park, No. 23, Nanxiang Second Road, Science City, Huangpu District, Guangzhou City, Guangdong Province Patentee after: Guangzhou Nanchuang Everest Medical Technology Co., Ltd. Address before: 610000 Office Building 308, Modern Industrial Center, Southwest Jiaotong University, 111 North Section of Second Ring Road, Jinniu District, Chengdu City, Sichuan Province Co-patentee before: Beijing Natong Technology Group Co., Ltd. Patentee before: Chengdu Dingfeng Forward-looking Technology Co., Ltd. |
|
TR01 | Transfer of patent right |